Impact of androgen deprivation therapy on mood, cognition, and risk for AD

Prostate cancer is the most common form of cancer diagnosed in men. Androgen deprivation therapy (ADT) is commonly prescribed, with some estimates indicating over 50% of men with prostate cancer receive ADT at some point in their treatment. Men on ADT are typically otherwise healthy, with good long-...

Full description

Saved in:
Bibliographic Details
Published in:Urologic oncology 2020-02, Vol.38 (2), p.53-61
Main Authors: Cherrier, Monique M., Higano, Celestia S.
Format: Article
Language:English
Subjects:
Affect - drug effects
Alzheimer Disease - chemically induced
Alzheimer's disease (AD)
Androgen Antagonists - adverse effects
Androgen deprivation therapy (ADT)
Cognition
Cognition - drug effects
Humans
Male
Mood
Prostate cancer
Risk Factors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Prostate cancer is the most common form of cancer diagnosed in men. Androgen deprivation therapy (ADT) is commonly prescribed, with some estimates indicating over 50% of men with prostate cancer receive ADT at some point in their treatment. Men on ADT are typically otherwise healthy, with good long-term survival. However, consequences of androgen deprivation can include side effects that may include changes in cognition or onset of dementia. This review will describe what is known about ADT and changes in cognitive function, the possible connection with Alzheimer's disease, how to discuss this with patients about to start ADT, and what patients can do to potentially mitigate cognitive changes.
ISSN:1078-1439
1873-2496
DOI:10.1016/j.urolonc.2019.01.021